medroxyprogesterone acetate has been researched along with Cancer of Prostate in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (58.82) | 18.7374 |
| 1990's | 14 (27.45) | 18.2507 |
| 2000's | 3 (5.88) | 29.6817 |
| 2010's | 4 (7.84) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bunce, C; Chong, MG; Davies, N; Drayson, M; Farmer, R; Gunther, U; Hayden, R; Khanim, F; Pararasa, C; Ride, J; Rigoreau, L; Trivier, E; Veerapen, N; Veliça, P; Winn, P | 1 |
| Aughenbaugh, J; Futia, GL; Gibson, EA; Potcoava, MC; Schlaepfer, IR | 1 |
| Bouchard, P; Irani, J; Mottet, N; Oba, R; Salomon, L | 1 |
| Cho, KS; Lee, JY | 1 |
| Baum, N | 1 |
| Amling, C; Cutting, B; Kramer, B; Lance, R; Langenstroer, P; Poultan, T; Thrasher, JB | 1 |
| Schroeder, FH | 1 |
| Aitini, E; Bajetta, E; Biganzoli, L; Bochicchio, AM; Buzzoni, R; Comella, G; D'Aprile, M; Di Leo, A; Nolè, F; Veltri, E | 1 |
| Anderström, C; Eddeland, A; Folmerz, P; Hansson, R; Milles, S; Zachrisson, B | 1 |
| Bergh, A; Damber, JE; Grankvist, K; Henriksson, R; Widmark, A | 1 |
| Anderström, C | 1 |
| Iacopino, F; Recchia, F; Sica, G | 1 |
| Hiipakka, RA; Kokontis, JM; Liao, S; Umekita, Y | 1 |
| Angström, T; Ljungberg, B; Tomic, R | 1 |
| Denis, L | 1 |
| Kurth, KH; Rietbroek, RL; van Andel, G; van De Velde-Muusers, JA | 1 |
| Abe, K | 1 |
| Sasagawa, I; Satomi, S | 1 |
| Bergh, A; Damber, JE; Landström, M; Tomić, R | 1 |
| Andersson, SO; Holmberg, L; Johansson, JE | 1 |
| Bezwoda, WR | 1 |
| Hagen, S; Holme, I; Klepp, O; Kloster, SE; Muri, O; Poulsen, C; Sander, S; Sivertsen, S; Tveter, KJ; Urnes, T | 1 |
| Cusan, L; Labrie, C; Labrie, F; Lapointe, S; Plante, M | 1 |
| Labrie, F; Lapointe, S; Plante, M | 1 |
| Charig, CR; Rundle, JS | 1 |
| Katayama, T; Sasagawa, I; Satomi, S | 1 |
| Ljungberg, B; Nilsson, TK; Tomic, R | 1 |
| de Pauw, M; de Voogt, HJ; Pavone-Macaluso, M; Smith, PH; Suciu, S; Sylvester, R | 1 |
| Katayama, T; Sasagawa, I; Satomi, S; Umeda, K | 1 |
| Bezwoda, WR; Derman, DP; Ruff, P; Weaving, A | 1 |
| Barasolo, E; de Pauw, M; de Voogt, HJ; Lardennois, B; Pavone-Macaluso, M; Schröder, FH; Smith, PH; Suciu, S; Sylvester, R; Viggiano, G | 1 |
| de Pauw, M; de Voogt, HJ; Pavone-Macaluso, M; Smith, PH; Suciu, S | 2 |
| Decensi, A; Pavesi, L; Prada, GA; Preti, P; Robustelli della Cuna, G; Zanon, P | 1 |
| Barasolo, E; de Pauw, M; de Voogt, HJ; Lardennois, B; Pavone-Macaluso, M; Sylvester, R; Viggiano, G | 1 |
| Fair, WR | 1 |
| Bensimon, H; Bunn, PA; Cohen, MH; Dunnick, NR; Eddy, JL; Ihde, DC; Javadpour, N; Makuch, RW; Minna, JD; Seifter, EJ | 1 |
| Damber, JE; Landström, M; Tomić, R | 1 |
| Barasolo, E; De Pauw, M; de Voogt, H; Ingargiola, GB; Lardennois, B; Pavone-Macaluso, M; Sylvester, R; Viggiano, G | 1 |
| Matsumoto, K; Noguchi, S | 1 |
| Flamm, J; Spona, J | 2 |
| Damber, JE; Ljungberg, B; Tomić, R | 2 |
| Debruyne, FM | 1 |
| Robinson, MR | 1 |
| deVoogt, HJ; Pavone-Macaluso, M; Schröder, FH; Sylvester, R | 1 |
| Gröhn, P; Kontturi, M; Lukkarinen, O; Romppainen, ML; Sotarauta, M; Tammela, T | 1 |
| Bollack, C; Rougeron, G | 1 |
| Fosså, SD; Haveland, H; Jahnsen, JU; Karlsen, S; Ogreid, P; Trovåg, A | 1 |
| Johansson, JE; Lingårdh, G | 1 |
5 review(s) available for medroxyprogesterone acetate and Cancer of Prostate
| Article | Year |
|---|---|
Experiences with doxo/epirubicin and medroxyprogesterone acetate (MPA) in prostatic cancer.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Epirubicin; Humans; Injections, Intramuscular; Male; Medroxyprogesterone Acetate; Orchiectomy; Prostatic Neoplasms; Survival Rate | 1994 |
Interferon and hormone sensitivity of endocrine-related tumors.
Topics: Androgens; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Hormones; Humans; Interferons; Male; Medroxyprogesterone Acetate; Prostatic Neoplasms; Tamoxifen; Tumor Cells, Cultured | 1996 |
[Hormone therapy of neoplasms].
Topics: Adenoma, Islet Cell; Aminoglutethimide; Breast Neoplasms; Female; Fluoxymesterone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Pancreatic Neoplasms; Prostatic Neoplasms; Tamoxifen | 1991 |
An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancer.
Topics: Administration, Oral; Carcinoma, Renal Cell; Clinical Trials as Topic; Diethylstilbestrol; Female; Humans; Injections, Intramuscular; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Prostatic Neoplasms; Uterine Neoplasms | 1986 |
Is there a best endocrine management of prostatic carcinoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Castration; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms | 1988 |
22 trial(s) available for medroxyprogesterone acetate and Cancer of Prostate
| Article | Year |
|---|---|
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
Topics: Adenocarcinoma; Androgen Antagonists; Autonomic Agents; Cyclohexanols; Cyproterone Acetate; Double-Blind Method; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Male; Medroxyprogesterone Acetate; Prospective Studies; Prostatic Neoplasms; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Treatment of prostatic cancer: the EORTC experience--preliminary results of prostatic carcinoma trials.
Topics: Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Doxorubicin; Estramustine; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Mitomycin; Mitomycins; Procarbazine; Prostatic Neoplasms; Random Allocation; Vinblastine; Vindesine | 1984 |
Epirubicin plus medroxyprogesterone as second-line treatment of advanced prostatic cancer. A study by the Italian Trials in Medical Oncology Group.
Topics: Aged; Ambulatory Care; Bone Neoplasms; Drug Synergism; Drug Therapy, Combination; Epirubicin; Heart Failure; Humans; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Pain; Pain Measurement; Palliative Care; Prostatic Neoplasms; Survival Analysis | 1995 |
Epirubicin and medroxyprogesterone acetate versus estramustine phosphate in hormone-resistant prostatic cancer: a prospective randomized study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Estramustine; Heart Failure; Humans; Male; Medroxyprogesterone Acetate; Prospective Studies; Prostatic Neoplasms; Recurrence | 1995 |
Experiences with doxo/epirubicin and medroxyprogesterone acetate (MPA) in prostatic cancer.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Epirubicin; Humans; Injections, Intramuscular; Male; Medroxyprogesterone Acetate; Orchiectomy; Prostatic Neoplasms; Survival Rate | 1994 |
European Organization for Research and Treatment of Cancer (EORTC) prostate cancer trials, 1976-1996.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Castration; Cyproterone Acetate; Diethylstilbestrol; Doxorubicin; Epirubicin; Estramustine; Flutamide; Humans; Imidazoles; Male; Medroxyprogesterone Acetate; Methotrexate; Mitomycin; Neoplasms, Hormone-Dependent; Procarbazine; Prostatic Neoplasms; Vindesine | 1998 |
Quality of life assessment in patients with hormone-resistant prostate cancer treated with epirubicin or with epirubicin plus medroxy progesterone acetate - is it feasible?
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Feasibility Studies; Humans; Male; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Prostatic Neoplasms; Quality of Life | 2000 |
High-dose medroxyprogesterone acetate versus estramustine in therapy-resistant prostatic cancer: a randomised study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Delayed-Action Preparations; Estramustine; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prognosis; Prostatic Neoplasms; Time Factors | 1991 |
Treatment of stage D2 prostatic cancer refractory to or relapsed following castration plus oestrogens. Comparison of aminoglutethimide plus hydrocortisone with medroxyprogesterone acetate plus hydrocortisone.
Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Diethylstilbestrol; Humans; Hydrocortisone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Staging; Orchiectomy; Postoperative Period; Prostatic Neoplasms; Randomized Controlled Trials as Topic | 1990 |
A randomized study on hormone-resistant prostatic cancer: estramustine phosphate versus low dose epirubicin with or without medroxyprogesterone acetate. A Norwegian multicenter study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Drug Therapy, Combination; Epirubicin; Estramustine; Humans; Injections, Intravenous; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norway; Placebos; Prospective Studies; Prostatic Neoplasms; Remission Induction | 1990 |
Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trials.
Topics: Adult; Aged; Aged, 80 and over; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Europe; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Multicenter Studies as Topic; Nitrogen Mustard Compounds; Prognosis; Prospective Studies; Prostatic Neoplasms; Random Allocation; Statistics as Topic | 1989 |
Sequential hormonal therapy and sequential hormonal and chemotherapy for advanced prostatic cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality Therapy; Diethylstilbestrol; Drug Administration Schedule; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Orchiectomy; Prostatic Neoplasms; Time Factors | 1989 |
EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group
Topics: Androgen Antagonists; Antineoplastic Agents; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Europe; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Multicenter Studies as Topic; Prostatic Neoplasms; Random Allocation | 1989 |
Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer tria
Topics: Aged; Body Weight; Cardiovascular Diseases; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Europe; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Nitrogen Mustard Compounds; Prostatic Neoplasms; Random Allocation; Time Factors | 1986 |
An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancer.
Topics: Administration, Oral; Carcinoma, Renal Cell; Clinical Trials as Topic; Diethylstilbestrol; Female; Humans; Injections, Intramuscular; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Prostatic Neoplasms; Uterine Neoplasms | 1986 |
Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological
Topics: Aged; Bone Neoplasms; Carcinoma; Cardiovascular Diseases; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Europe; Follow-Up Studies; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prostatic Neoplasms; Random Allocation | 1986 |
A trial of combination chemotherapy followed by hormonal therapy for previously untreated metastatic carcinoma of the prostate.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Doxorubicin; Drug Therapy, Combination; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Orchiectomy; Pilot Projects; Prostatic Neoplasms | 1986 |
Cyproterone acetate versus medroxyprogesterone acetate versus diethylstilbestrol in the treatment of prostate cancer: results from EORTC Study 30761.
Topics: Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms | 1987 |
Lessons from phase III-trials on the hormonal treatment of prostatic cancer. I: Results of EORTC-trials 30761 and 30762.
Topics: Antineoplastic Agents; Carcinoma; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Drug Administration Schedule; Estramustine; Europe; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms; Random Allocation | 1988 |
Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.
Topics: Aged; Buserelin; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Orchiectomy; Prostatic Neoplasms; Remission Induction; Time Factors | 1988 |
Is there a best endocrine management of prostatic carcinoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Castration; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms | 1988 |
Re: Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Heart; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms | 1988 |
27 other study(ies) available for medroxyprogesterone acetate and Cancer of Prostate
| Article | Year |
|---|---|
Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Breast Neoplasms; Drug Interactions; Enzyme Inhibitors; Female; Humans; Hydroxyprostaglandin Dehydrogenases; Leukemia; Male; Mass Spectrometry; Medroxyprogesterone Acetate; Prostatic Neoplasms; Substrate Specificity | 2014 |
Raman and coherent anti-Stokes Raman scattering microscopy studies of changes in lipid content and composition in hormone-treated breast and prostate cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Female; Humans; Lipid Droplets; Lipids; Male; Medroxyprogesterone Acetate; Metribolone; Microscopy; Molecular Imaging; Prostatic Neoplasms; Spectrum Analysis, Raman | 2014 |
Chemical castration for sexual offenders: physicians' views.
Topics: Castration; Cyproterone Acetate; Gonadotropin-Releasing Hormone; Humans; Male; Medroxyprogesterone Acetate; Physicians; Prostatic Neoplasms; Psychotherapy; Sex Offenses | 2013 |
How to manage hot flashes in prostate cancer?
Topics: Administration, Oral; Antineoplastic Agents, Hormonal; Belladonna Alkaloids; Diethylstilbestrol; Dose-Response Relationship, Drug; Drug Combinations; Ergotamines; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Injections, Intramuscular; Male; Medroxyprogesterone Acetate; Megestrol Acetate; Methysergide; Middle Aged; Phenobarbital; Prostatic Neoplasms | 2003 |
Parenteral medroxyprogesterone for the management of luteinizing hormone releasing hormone induced hot flashes in men with advanced prostate cancer.
Topics: Androgen Antagonists; Contraceptive Agents, Male; Hot Flashes; Humans; Injections, Intramuscular; Male; Medroxyprogesterone Acetate; Prostatic Neoplasms; Retrospective Studies | 2005 |
Effects of estrogens and progestogens on the membrane permeability and growth of human prostatic carcinoma cells (PC-3) in vitro.
Topics: Adenocarcinoma; Cell Membrane Permeability; Estrogens; Humans; Male; Medroxyprogesterone Acetate; Progestins; Prostatic Neoplasms; Rubidium Radioisotopes; Tumor Cells, Cultured | 1995 |
Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride.
Topics: Androgen-Binding Protein; Animals; Cell Division; Cell Line; Dihydrotestosterone; DNA Primers; Drug Implants; Enzyme Inhibitors; Estradiol; Finasteride; Humans; Male; Medroxyprogesterone Acetate; Mice; Mice, Nude; Orchiectomy; Polymerase Chain Reaction; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Time Factors; Transplantation, Heterologous | 1996 |
Cellular changes in prostatic carcinoma after treatment with orchidectomy, estramustine phosphate and medroxyprogesterone acetate.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biopsy, Needle; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Estramustine; Humans; Male; Medroxyprogesterone Acetate; Middle Aged; Orchiectomy; Prostate; Prostatic Neoplasms | 1997 |
Effect of high-dose medroxyprogesterone acetate on plasma hormone levels and pain relief in patients with advanced prostatic cancer.
Topics: Adrenocorticotropic Hormone; Aged; Antineoplastic Agents; Bone Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Follicle Stimulating Hormone; Gonadotropins; Growth Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Palliative Care; Prolactin; Prostatic Neoplasms; Thyrotropin | 1990 |
Treatment of rat prostatic adenocarcinoma with medroxyprogesterone acetate (MPA): effects on growth and morphology.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Castration; Estradiol; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms; Rats; Rats, Inbred F344; Testosterone | 1991 |
Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer.
Topics: Adrenal Glands; Animals; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Flutamide; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Organ Size; Ornithine Decarboxylase; Progesterone Congeners; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Spironolactone | 1987 |
Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive Shionogi tumor in mice.
Topics: Androgens; Animals; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Female; Flutamide; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Mice; Progesterone Congeners; Prostatic Neoplasms | 1988 |
Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma.
Topics: Aged; Aged, 80 and over; Flushing; Follicle Stimulating Hormone; Humans; Hydroxyindoleacetic Acid; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Orchiectomy; Pilot Projects; Prolactin; Prostatic Neoplasms; Vanilmandelic Acid | 1989 |
[Remarkable pain relief in the treatment with high-dose medroxyprogesterone acetate in advanced prostatic carcinoma].
Topics: Adrenocorticotropic Hormone; Back Pain; Bone and Bones; Bone Neoplasms; Chlormadinone Acetate; Dehydroepiandrosterone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging | 1989 |
Effects of high dose medroxyprogesterone acetate treatment on antithrombin III and other plasma proteins in males with renal cell or prostatic carcinoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antithrombin III; Blood Proteins; Carcinoma, Renal Cell; Delayed-Action Preparations; Haptoglobins; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms | 1989 |
[Pain relief by high-dose medroxyprogesterone acetate in advanced prostatic cancer].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Agents; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pain, Intractable; Prostatic Neoplasms | 1989 |
Hormonal therapy of advanced prostatic cancer.
Topics: Antineoplastic Agents; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms | 1986 |
Effect of medroxyprogesterone acetate, alone or in combination with epirubicin hydrochloride, on the growth of the Dunning R3327H prostatic adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Doxorubicin; Epirubicin; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Transplantation; Orchiectomy; Prostatic Neoplasms; Rats; Testosterone | 1987 |
[Hormone therapy--recent advances].
Topics: Breast Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptors, Androgen; Receptors, Estrogen; Tamoxifen; Uterine Neoplasms | 1987 |
[High-dosage medroxyprogesterone acetate treatment in advanced prostatic cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Dose-Response Relationship, Drug; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Testosterone | 1987 |
The influence of medroxyprogesterone acetate (MPA) on hormone parameters in prostatic carcinoma patients.
Topics: Aged; Aged, 80 and over; Carcinoma; Dose-Response Relationship, Drug; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Orchiectomy; Prostatic Neoplasms; Testosterone | 1988 |
Hormonal effects of high dose medroxyprogesterone acetate treatment in males with renal or prostatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Dehydroepiandrosterone; Estradiol; Follicle Stimulating Hormone; Hormones; Humans; Hydrocortisone; Kidney Neoplasms; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prolactin; Prostatic Neoplasms; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 1988 |
Endocrinological effects of treatment with high doses of medroxyprogesterone acetate in patients with renal or prostatic adenocarcinoma.
Topics: Adenocarcinoma; Androgens; Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms; Sex Hormone-Binding Globulin | 1988 |
Sequentially alternating hormone chemotherapy with high-dose medroxy-progesterone acetate and low-dose epirubicin for the treatment of hormone-resistant metastatic prostatic cancer.
Topics: Actuarial Analysis; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Drug Administration Schedule; Drug Evaluation; Epirubicin; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prostatic Neoplasms | 1988 |
Hormonal therapy trials in prostatic cancer. An EORTC Genitourinary Group study.
Topics: Androgen Antagonists; Carcinoma; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Europe; Gonadotropin-Releasing Hormone; Hormones; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms | 1988 |
High-dose medroxyprogesterone acetate versus prednisolone in hormone-resistant prostatic cancer. A pilot study.
Topics: Acid Phosphatase; Aged; Antineoplastic Agents; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Pilot Projects; Prednisolone; Prostatic Neoplasms; Random Allocation; Time Factors | 1985 |
High-dose medroxyprogesterone in the treatment of advanced therapy-resistant prostatic carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma; Combined Modality Therapy; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prostatic Neoplasms | 1985 |